Human Genome Epidemiology Literature Finder
Records 1 - 26 (of 26 Records) |
Query Trace: Neoplasms and TPMT[original query] |
---|
A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of colorectal cancer. Pharmacogenetics and genomics 2005 Aug 15 (8): 535-46. Landi Stefano, Gemignani Federica, Moreno Victor, Gioia-Patricola Lydie, Chabrier Amélie, Guino Elisabeth, Navarro Matilde, de Oca Javier, Capellà Gabriel, Canzian Federico, |
TPMT genetic variations in populations of the Russian Federation. Pediatric blood & cancer 2009 Feb 52 (2): 203-8. Samochatova Elena V, Chupova Natalia V, Rudneva Anastassia, Makarova Olga, Nasedkina Tatyana V, Fedorova Olga E, Glotov Andrei S, Kozhekbaeva Zh, Maiorova Olga A, Roumyantsev Alexander G, Krynetski Eugene Y, Krynetskaia Natalia F, Evans William E, Ribeiro Raul |
MTHFR and TYMS genotypes influence TPMT activity and its differential modulation in males and females. Clinical biochemistry 2010 Jan 43 (1-2): 37-42. Karas-Kuzelicki Natasa, Milek Miha, Mlinaric-Rascan Ire |
TPMT and DPD polymorphisms: Efficient screening method for Indian patients considering taking Thiopurine and 5-FU drugs. Disease markers 2009 27 (5): 5. Ashavaid TF, Raghavan R, Shah S, Kapadia A, Almel S, Desai D |
SNPs in genes coding for ROS metabolism and signalling in association with docetaxel clearance. The pharmacogenomics journal 2010 Dec 10 (6): 513-23. Edvardsen H, Brunsvig P F, Solvang H, Tsalenko A, Andersen A, Syvanen A-C, Yakhini Z, Børresen-Dale A-L, Olsen H, Aamdal S, Kristensen V |
Genetic polymorphisms of NQO1, CYP1A1 and TPMT and susceptibility to acute lymphoblastic leukemia in a Tunisian population. Molecular biology reports 2012 Oct . Ouerhani S, Cherif N, Bahri I, Safra I, Menif S, Abbes S |
[Analysis of genetic polymorphisms of thiopurine S-methyltransferase (TPMT) in Mexican pediatric patients with cancer]. Revista de investigación clínica; organo del Hospital de Enfermedades de la Nutrición 0 65 (2): 156-64. Moreno-Guerrero Silvia Selene, Ramírez-Pacheco Arturo, Dorantes-Acosta Elsa María, Medina-Sanson Auro |
Pharmacogenomic assessment of cisplatin-based chemotherapy outcomes in ovarian cancer. Pharmacogenomics 2014 Feb 15 (3): 329-37. Khrunin Andrey V, Khokhrin Denis V, Moisseev Alexey A, Gorbunova Vera A, Limborska Svetlana |
Influence of genetic variants in TPMT and COMT associated with cisplatin induced hearing loss in patients with cancer: two new cohorts and a meta-analysis reveal significant heterogeneity between cohorts. PloS one 2014 9 (12): e115869. Hagleitner Melanie M, Coenen Marieke J H, Patino-Garcia Ana, de Bont Eveline S J M, Gonzalez-Neira Anna, Vos Hanneke I, van Leeuwen Frank N, Gelderblom Hans, Hoogerbrugge Peter M, Guchelaar Henk-Jan, Te Loo Maroeska W |
NUDT15 and TPMT genetic polymorphisms are related to 6-mercaptopurine intolerance in children treated for acute lymphoblastic leukemia at the Children's Cancer Center of Lebanon. Pediatric blood & cancer 2016 Aug . Zgheib Nathalie K, Akika Reem, Mahfouz Rami, Aridi Carol Al, Ghanem Khaled M, Saab Raya, Abboud Miguel R, Tarek Nidale, El Solh Hassan, Muwakkit Samar |
Risk factors for symptomatic osteonecrosis in childhood ALL: A retrospective study of a Slovenian pediatric ALL population between 1970 and 2004. Experimental and therapeutic medicine 2016 Aug 12 (2): 840-846. Karas-Kuželi?ki Nataša, Mencej-Bedra? Simona, Jazbec Janez, Marc Janja, Mlinari?-Raš?an Ire |
Association of genetic variability in enzymes metabolizing chemotherapeutic agents with treatment response in head and neck cancer cases. Asia-Pacific journal of clinical oncology 2016 Jan . Dhawan Ankur, Ruwali Munindra, Pant Mohan C, Rahman Qamar, Parmar Devend |
TPMT, COMT and ACYP2 genetic variants in paediatric cancer patients with cisplatin-induced ototoxicity. Pharmacogenetics and genomics 2017 Apr . Thiesen Signe, Yin Peng, Jorgensen Andrea L, Zhang Jieying E, Manzo Valentina, McEvoy Laurence, Barton Christopher, Picton Susan, Bailey Simon, Brock Penelope, Vyas Harish, Walker David, Makin Guy, Bandi Srinivas, Pizer Barry, Hawcutt Daniel B, Pirmohamed Mun |
Influence of thiopurine S-methyltransferase polymorphisms in mercaptopurine pharmacokinetics in healthy volunteers. Basic & clinical pharmacology & toxicology 2019 Apr 124 (4): 449-455. Saiz-Rodríguez Miriam, Ochoa Dolores, Belmonte Carmen, Román Manuel, Martínez-Ingelmo Cristina, Ortega-Ruíz Lucía, Sarmiento-Iglesias Carmen, Herrador Coral, Abad-Santos Francis |
Genetic Polymorphism of Thiopurine S-methyltransferase in Children with Acute Lymphoblastic Leukemia in Jordan. Asian Pacific journal of cancer prevention : APJCP 2018 Jan 19 (1): 199-205. Alsous Mervat, Yousef Al-Motassem, Abdel Jalil Mariam, Zawiah Mohammed, Yacoub Shorouq, Momani Deema, Gharabli Alia, Omar Suha, Rihani Raw |
ITPA, TPMT, and NUDT15 Genetic Polymorphisms Predict 6-Mercaptopurine Toxicity in Middle Eastern Children With Acute Lymphoblastic Leukemia. Frontiers in pharmacology 2019 9 10 916. Moradveisi Borhan, Muwakkit Samar, Zamani Fatemeh, Ghaderi Ebrahim, Mohammadi Ebrahim, Zgheib Nathalie |
Genetic Variants as Predictive Markers for Ototoxicity and Nephrotoxicity in Patients with Locally Advanced Head and Neck Cancer Treated with Cisplatin-Containing Chemoradiotherapy (The PRONE Study). Cancers 2019 Apr 11 (4): . Driessen Chantal M, Ham Janneke C, Te Loo Maroeska, van Meerten Esther, van Lamoen Maurits, Hakobjan Marina H, Takes Robert P, van der Graaf Winette T, Kaanders Johannes H, Coenen Marieke J H, van Herpen Carla |
Association between the TPMT*3C (rs1142345) Polymorphism and the Risk of Death in the Treatment of Acute Lymphoblastic Leukemia in Children from the Brazilian Amazon Region. Genes 2020 9 11 (10): . Cardoso de Carvalho Darlen, Pereira Colares Leitão Luciana, Mello Junior Fernando Augusto Rodrigues, Vieira Wanderley Alayde, Souza Tatiane Piedade de, Borges Andrade de Sá Roberta, Cohen-Paes Amanda, Rodrigues Fernandes Marianne, Santos Sidney, Salim Khayat André, Pimentel de Assumpção Paulo, Pereira Carneiro Dos Santos N |
Association of candidate pharmacogenetic markers with platinum-induced ototoxicity: PanCareLIFE dataset. Data in brief 2020 9 32 106227. Langer Thorsten, Clemens Eva, Broer Linda, Maier Lara, Uitterlinden André G, de Vries Andrica C H, van Grotel Martine, Pluijm Saskia F M, Binder Harald, Mayer Benjamin, von dem Knesebeck Annika, Byrne Julianne, van Dulmen-den Broeder Eline, Crocco Marco, Grabow Desiree, Kaatsch Peter, Kaiser Melanie, Spix Claudia, Kenborg Line, Winther Jeanette F, Rechnitzer Catherine, Hasle Henrik, Kepak Tomas, van der Kooi Anne-Lotte F, Kremer Leontien C, Kruseova Jarmila, Bielack Stefan, Sorg Benjamin, Hecker-Nolting Stefanie, Kuehni Claudia E, Ansari Marc, Kompis Martin, van der Pal Heleen J, Parfitt Ross, Deuster Dirk, Matulat Peter, Tillmanns Amelie, Tissing Wim J E, Beck Jörn D, Elsner Susanne, Am Zehnhoff-Dinnesen Antoinette, van den Heuvel-Eibrink Marry M, Zolk Oliver, |
[Analysis of carrying clinically significant allelic variants of TPMT and DPYD genes associated with the response to drug therapy in cancer practice among 9 ethnic groups of the Russian Federation]. Terapevticheskii arkhiv 2020 Sep 92 (8): 43-51. Mirzaev K B, Fedorinov D S, Akmalova K A, Abdullaev S P, Kachanova A A, Sozaeva Z A, Grishina E A, Shuev G N, Kitaeva E Y, Shprakh V V, Suleymanov S S, Bolieva L Z, Sozaeva M S, Zhuchkova S M, Gimaldinova N E, Sidukova E E, Burashnikova I S, Shikaleva A A, Zabudskaya K G, Sychev D |
[Genetic basis of subsequent malignant neoplasms]. [Rinsho ketsueki] The Japanese journal of clinical hematology 2020 61 (9): 1174-1178. Yoshida Masanori, Kato Motohi |
Population impact of pharmacogenetic tests in admixed populations across the Americas. The pharmacogenomics journal 2020 10 21 (2): 216-221. Suarez-Kurtz Guilher |
TPMT Genetic Variability and Its Association with Hematotoxicity in Indonesian Children with Acute Lymphoblastic Leukemia in Maintenance Therapy. Pharmacogenomics and personalized medicine 2021 2 14 199-210. Rosdiana Dewi Selvina, Setiabudy Rianto, Andalusia Rizka, Gatot Djajadiman, Louisa Melva, Bardosono Saptawati, Instiaty Instia |
Prominence of NUDT15 genetic variation associated with 6-mercaptopurine tolerance in a genome-wide association study of Japanese children with acute lymphoblastic leukaemia.
![]() British journal of haematology 2022 Aug . Tanaka Yoichi, Urayama Kevin Y, Mori Makiko, Arakawa Yuki, Hasegawa Daisuke, Noguchi Yasushi, Yanagimachi Masakatsu, Keino Dai, Ota Setsuo, Akahane Koshi, Inukai Takeshi, Hangai Mayumi, Kawaguchi Takahisa, Takagi Masatoshi, Koh Katsuyoshi, Matsuda Fumihiko, Manabe Atsus |
Clinically actionable genotypes for anticancer prescribing among >1500 patients with pharmacogenomic testing. Cancer 2022 1 128 (8): 1649-1657. Reizine Natalie M, Danahey Keith, Truong Tien M, George David, House Larry K, Karrison Theodore G, van Wijk Xander M R, Yeo Kiang-Teck J, Ratain Mark J, O'Donnell Peter |
Sequencing of genes of drug response in tumor DNA and implications for precision medicine in cancer patients. The pharmacogenomics journal 2023 1 . Gillis Nancy, Etheridge Amy S, Patil Sushant A, Hayes D Neil, Hayward Michele C, Auman J Todd, Parker Joel S, Innocenti Federi |
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 29, 2023
- Content source: